Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.
Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana.
J Ren Nutr. 2020 Sep;30(5):384-395. doi: 10.1053/j.jrn.2019.11.002. Epub 2020 Jan 9.
It is increasingly recognized that the gut microbiota plays a role in the progression of chronic diseases and that diet may confer health benefits by altering the gut microbiota composition. This is of particular relevance for chronic kidney disease (CKD), as the gut is a source of uremic retention solutes, which accumulate as a result of impaired kidney function and can exert nephrotoxic and other harmful effects. Kidney dysfunction is also associated with changes in the composition of the gut microbiota and the gastrointestinal tract. Diet modulates the gut microbiota, and there is much interest in the use of prebiotics, probiotics, and synbiotics as dietary therapies in CKD, as well as dietary patterns that beneficially alter the microbiota. This review provides an overview of the gut microbiota and its measurement, its relevance in the context of CKD, and the current state of knowledge regarding dietary manipulation of the microbiota.
人们越来越认识到,肠道微生物群在慢性病的进展中发挥作用,而饮食可能通过改变肠道微生物群的组成来带来健康益处。这对于慢性肾脏病(CKD)尤其重要,因为肠道是尿毒症溶质的来源,这些溶质由于肾功能受损而积累,并可能产生肾毒性和其他有害影响。肾功能障碍也与肠道微生物群和胃肠道组成的变化有关。饮食调节肠道微生物群,人们对使用益生元、益生菌和合生菌作为 CKD 的饮食疗法以及有益地改变微生物群的饮食模式非常感兴趣。这篇综述概述了肠道微生物群及其测量方法,以及它在 CKD 背景下的相关性,以及关于饮食对微生物群的操纵的现有知识状态。